Long Read Analysis in Spinal Muscular Atrophy - LOREASI

Abroad (travel likely)Recruiting

Conditions

Spinal Muscular Atrophy (SMA)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHU Rouen, Rouen, France
Contact: Study coordinator (Pascale Saugier-Veber) · Pascale.Saugier-Veber@chu-rouen.fr · (+33) 2 32 88 64 51

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy

Spinal Muscular Atrophy (SMA)

Abroad (travel likely)RecruitingPHASE2

Little Rock, United States · San Diego, United States

VRehab-SMA Phase 1.2

Spinal Muscular Atrophy (SMA)

Abroad (travel likely)Recruiting

Oxford, United Kingdom

Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers

Spinal Muscular Atrophy (SMA) · Charcot-Marie-Tooth · Muscular Dystrophy

Abroad (travel likely)Recruiting

Paris, France

Characterizing Perceived Physical Fatigability in Nusinersen-treated SMA

Spinal Muscular Atrophy

Abroad (travel likely)Recruiting

New York, United States